ORBIMED ADVISORS LLC
Top Portfolio Positions
106 positions ·
$5,343,151,020 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MYGN |
Myriad Genetics Inc
Healthcare
|
125,000,000 | $562,500,000 | 10.53% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
15,518,492 | $488,832,498 | 9.15% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
7,959,538 | $312,013,889 | 5.84% | |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
82,010,995 | $303,440,681 | 5.68% | |
| MDXH |
MDxHealth SA
Healthcare
|
124,306,000 | $285,903,800 | 5.35% | |
| LLY |
ELI LILLY & Co
Healthcare
|
236,800 | $217,801,536 | 4.08% | |
| BSX |
Boston Scientific Corp
Healthcare
|
2,382,100 | $149,476,775 | 2.80% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
3,530,702 | $141,545,843 | 2.65% | |
| AZN |
Astrazeneca PLC
Healthcare
|
670,200 | $132,176,844 | 2.47% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
3,637,887 | $108,590,926 | 2.03% |
Portfolio Trend
24 quarters · across all stocks
Holdings in SPRY
Shares Held
Position Value (USD)
21 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,556,735 | 8,288,510 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $96,561,141 | 8,288,510 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $144,634,499 | 8,288,510 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $104,269,455 | 8,288,510 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $87,443,780 | 8,288,510 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $120,183,395 | 8,288,510 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $78,639,948 | 9,240,887 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $94,441,865 | 9,240,887 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $50,640,060 | 9,240,887 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $34,930,552 | 9,240,887 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $58,563,942 | 8,740,887 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $56,903,174 | 8,740,887 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $74,559,766 | 8,740,887 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $46,151,883 | 8,740,887 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,061,360 | 8,740,887 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $30,680,513 | 8,740,887 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $58,214,307 | 8,740,887 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $87,234,052 | 8,740,887 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $270,005,999 | 8,740,887 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $381,364,899 | 8,740,887 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $405,052,703 | 8,740,887 | Shares | Defined | 2021-02-16 | |
| No 13F history on record for this holder in this stock. | ||||||